Dichloralphenazone is a sedative composed of chloral hydrate and phenazone. It is typically found in combination products Nodolor and Midrin containing isometheptene and acetaminophen used for the relief of tension and vascular headaches. It is a US Schedule IV drug and its clinical use is limited.
Fitur visualisasi ini dikembangkan menggunakan pendekatan Graph Theory untuk memetakan hubungan polifarmasi dan molekuler. Entitas (Obat, Target, Gen) direpresentasikan sebagai Simpul (Nodes), sedangkan hubungan biologisnya sebagai Sisi (Edges).
drugbank-id dan name pada skema XML DrugBank.targets/target yang memuat polipeptida sasaran.gene-name dan varian snp-effects.Tata letak grafik menggunakan algoritma Force-Directed Graph (Barnes-Hut). Model fisika ini menerapkan gaya tolak-menolak antar simpul (Gravitasi: -3000) agar tidak tumpang tindih, serta gaya pegas (Spring: 0.04) pada garis penghubung untuk fleksibilitas interaksi.
| Buprenorphine | Dichloralphenazone may increase the central nervous system depressant (CNS depressant) activities of Buprenorphine. |
| Doxylamine | Doxylamine may increase the central nervous system depressant (CNS depressant) activities of Dichloralphenazone. |
| Dronabinol | Dronabinol may increase the central nervous system depressant (CNS depressant) activities of Dichloralphenazone. |
| Droperidol | Droperidol may increase the central nervous system depressant (CNS depressant) activities of Dichloralphenazone. |
| Hydrocodone | Dichloralphenazone may increase the central nervous system depressant (CNS depressant) activities of Hydrocodone. |
| Hydroxyzine | Hydroxyzine may increase the central nervous system depressant (CNS depressant) activities of Dichloralphenazone. |
| Magnesium sulfate | The therapeutic efficacy of Dichloralphenazone can be increased when used in combination with Magnesium sulfate. |
| Methotrimeprazine | Dichloralphenazone may increase the central nervous system depressant (CNS depressant) activities of Methotrimeprazine. |
| Metyrosine | Dichloralphenazone may increase the sedative activities of Metyrosine. |
| Minocycline | Minocycline may increase the central nervous system depressant (CNS depressant) activities of Dichloralphenazone. |
| Mirtazapine | Dichloralphenazone may increase the central nervous system depressant (CNS depressant) activities of Mirtazapine. |
| Nabilone | Nabilone may increase the central nervous system depressant (CNS depressant) activities of Dichloralphenazone. |
| Orphenadrine | Dichloralphenazone may increase the central nervous system depressant (CNS depressant) activities of Orphenadrine. |
| Paraldehyde | Dichloralphenazone may increase the central nervous system depressant (CNS depressant) activities of Paraldehyde. |
| Perampanel | Perampanel may increase the central nervous system depressant (CNS depressant) activities of Dichloralphenazone. |
| Pramipexole | Dichloralphenazone may increase the sedative activities of Pramipexole. |
| Ropinirole | Dichloralphenazone may increase the sedative activities of Ropinirole. |
| Rotigotine | Dichloralphenazone may increase the sedative activities of Rotigotine. |
| Rufinamide | The risk or severity of adverse effects can be increased when Rufinamide is combined with Dichloralphenazone. |
| Suvorexant | Dichloralphenazone may increase the central nervous system depressant (CNS depressant) activities of Suvorexant. |
| Tapentadol | Tapentadol may increase the central nervous system depressant (CNS depressant) activities of Dichloralphenazone. |
| Thalidomide | Dichloralphenazone may increase the central nervous system depressant (CNS depressant) activities of Thalidomide. |
| Zolpidem | Dichloralphenazone may increase the central nervous system depressant (CNS depressant) activities of Zolpidem. |
| Methadone | The risk or severity of adverse effects can be increased when Methadone is combined with Dichloralphenazone. |
| Sodium oxybate | Dichloralphenazone may increase the central nervous system depressant (CNS depressant) activities of Sodium oxybate. |
| Ethanol | Dichloralphenazone may increase the central nervous system depressant (CNS depressant) activities of Ethanol. |
| Azelastine | Dichloralphenazone may increase the central nervous system depressant (CNS depressant) activities of Azelastine. |
| Brimonidine | Brimonidine may increase the central nervous system depressant (CNS depressant) activities of Dichloralphenazone. |
| Fluvoxamine | The risk or severity of adverse effects can be increased when Dichloralphenazone is combined with Fluvoxamine. |
| Citalopram | The risk or severity of adverse effects can be increased when Dichloralphenazone is combined with Citalopram. |
| Duloxetine | The risk or severity of adverse effects can be increased when Dichloralphenazone is combined with Duloxetine. |
| Trazodone | The risk or severity of adverse effects can be increased when Dichloralphenazone is combined with Trazodone. |
| Paroxetine | The risk or severity of adverse effects can be increased when Dichloralphenazone is combined with Paroxetine. |
| Sertraline | The risk or severity of adverse effects can be increased when Dichloralphenazone is combined with Sertraline. |
| Sibutramine | The risk or severity of adverse effects can be increased when Dichloralphenazone is combined with Sibutramine. |
| Nefazodone | The risk or severity of adverse effects can be increased when Dichloralphenazone is combined with Nefazodone. |
| Escitalopram | The risk or severity of adverse effects can be increased when Dichloralphenazone is combined with Escitalopram. |
| Zimelidine | The risk or severity of adverse effects can be increased when Dichloralphenazone is combined with Zimelidine. |
| Dapoxetine | The risk or severity of adverse effects can be increased when Dichloralphenazone is combined with Dapoxetine. |
| Milnacipran | The risk or severity of adverse effects can be increased when Dichloralphenazone is combined with Milnacipran. |
| Desvenlafaxine | The risk or severity of adverse effects can be increased when Dichloralphenazone is combined with Desvenlafaxine. |
| Seproxetine | The risk or severity of adverse effects can be increased when Dichloralphenazone is combined with Seproxetine. |
| Indalpine | The risk or severity of adverse effects can be increased when Dichloralphenazone is combined with Indalpine. |
| Ritanserin | The risk or severity of adverse effects can be increased when Dichloralphenazone is combined with Ritanserin. |
| Alaproclate | The risk or severity of adverse effects can be increased when Dichloralphenazone is combined with Alaproclate. |
| Amitriptyline | The risk or severity of CNS depression can be increased when Amitriptyline is combined with Dichloralphenazone. |
| Cyproheptadine | The risk or severity of CNS depression can be increased when Cyproheptadine is combined with Dichloralphenazone. |
| Imipramine | The risk or severity of CNS depression can be increased when Imipramine is combined with Dichloralphenazone. |
| Nortriptyline | The risk or severity of CNS depression can be increased when Nortriptyline is combined with Dichloralphenazone. |
| Amoxapine | The risk or severity of CNS depression can be increased when Amoxapine is combined with Dichloralphenazone. |
| Propiomazine | The risk or severity of CNS depression can be increased when Propiomazine is combined with Dichloralphenazone. |
| Maprotiline | The risk or severity of CNS depression can be increased when Maprotiline is combined with Dichloralphenazone. |
| Doxepin | The risk or severity of CNS depression can be increased when Doxepin is combined with Dichloralphenazone. |
| Desipramine | The risk or severity of CNS depression can be increased when Desipramine is combined with Dichloralphenazone. |
| Pizotifen | The risk or severity of CNS depression can be increased when Dichloralphenazone is combined with Pizotifen. |
| Dosulepin | The risk or severity of CNS depression can be increased when Dichloralphenazone is combined with Dosulepin. |
| Zopiclone | The risk or severity of adverse effects can be increased when Dichloralphenazone is combined with Zopiclone. |
| Botulinum toxin type B | The risk or severity of CNS depression can be increased when Botulinum toxin type B is combined with Dichloralphenazone. |
| Botulinum toxin type A | The risk or severity of CNS depression can be increased when Botulinum toxin type A is combined with Dichloralphenazone. |
| Tryptophan | The risk or severity of CNS depression can be increased when Tryptophan is combined with Dichloralphenazone. |
| Baclofen | Baclofen may increase the central nervous system depressant (CNS depressant) activities of Dichloralphenazone. |
| Lorazepam | The risk or severity of CNS depression can be increased when Lorazepam is combined with Dichloralphenazone. |
| Ethchlorvynol | The risk or severity of CNS depression can be increased when Ethchlorvynol is combined with Dichloralphenazone. |
| Succinylcholine | The risk or severity of CNS depression can be increased when Succinylcholine is combined with Dichloralphenazone. |
| Reserpine | The risk or severity of CNS depression can be increased when Reserpine is combined with Dichloralphenazone. |
| Eletriptan | The risk or severity of CNS depression can be increased when Eletriptan is combined with Dichloralphenazone. |
| Enflurane | The risk or severity of CNS depression can be increased when Enflurane is combined with Dichloralphenazone. |
| Temazepam | The risk or severity of CNS depression can be increased when Temazepam is combined with Dichloralphenazone. |
| Reboxetine | The risk or severity of CNS depression can be increased when Reboxetine is combined with Dichloralphenazone. |
| Butabarbital | The risk or severity of CNS depression can be increased when Butabarbital is combined with Dichloralphenazone. |
| Butalbital | The risk or severity of CNS depression can be increased when Butalbital is combined with Dichloralphenazone. |
| Methysergide | The risk or severity of CNS depression can be increased when Methysergide is combined with Dichloralphenazone. |
| Cabergoline | The risk or severity of CNS depression can be increased when Cabergoline is combined with Dichloralphenazone. |
| Phenytoin | The risk or severity of CNS depression can be increased when Phenytoin is combined with Dichloralphenazone. |
| Topiramate | The risk or severity of CNS depression can be increased when Topiramate is combined with Dichloralphenazone. |
| Clemastine | The risk or severity of CNS depression can be increased when Clemastine is combined with Dichloralphenazone. |
| Venlafaxine | The risk or severity of CNS depression can be increased when Venlafaxine is combined with Dichloralphenazone. |
| Etomidate | The risk or severity of CNS depression can be increased when Etomidate is combined with Dichloralphenazone. |
| Morphine | The risk or severity of CNS depression can be increased when Morphine is combined with Dichloralphenazone. |
| Talbutal | The risk or severity of CNS depression can be increased when Talbutal is combined with Dichloralphenazone. |
| Pentobarbital | The risk or severity of CNS depression can be increased when Pentobarbital is combined with Dichloralphenazone. |
| Valproic acid | The risk or severity of CNS depression can be increased when Valproic acid is combined with Dichloralphenazone. |
| Zolmitriptan | The risk or severity of CNS depression can be increased when Zolmitriptan is combined with Dichloralphenazone. |
| Codeine | The risk or severity of CNS depression can be increased when Codeine is combined with Dichloralphenazone. |
| Dihydroergotamine | The risk or severity of CNS depression can be increased when Dihydroergotamine is combined with Dichloralphenazone. |
| Tolcapone | The risk or severity of CNS depression can be increased when Tolcapone is combined with Dichloralphenazone. |
| Hydromorphone | The risk or severity of CNS depression can be increased when Hydromorphone is combined with Dichloralphenazone. |
| Olanzapine | The risk or severity of CNS depression can be increased when Olanzapine is combined with Dichloralphenazone. |
| Cetirizine | The risk or severity of CNS depression can be increased when Cetirizine is combined with Dichloralphenazone. |
| Protriptyline | The risk or severity of CNS depression can be increased when Protriptyline is combined with Dichloralphenazone. |
| Trimethadione | The risk or severity of CNS depression can be increased when Trimethadione is combined with Dichloralphenazone. |
| Clobazam | The risk or severity of sedation, somnolence, and CNS depression can be increased when Clobazam is combined with Dichloralphenazone. |
| Chlorzoxazone | The risk or severity of CNS depression can be increased when Chlorzoxazone is combined with Dichloralphenazone. |
| Clozapine | The risk or severity of CNS depression can be increased when Clozapine is combined with Dichloralphenazone. |
| Meprobamate | The risk or severity of CNS depression can be increased when Meprobamate is combined with Dichloralphenazone. |
| Thiethylperazine | The risk or severity of CNS depression can be increased when Thiethylperazine is combined with Dichloralphenazone. |
| Palonosetron | The risk or severity of CNS depression can be increased when Palonosetron is combined with Dichloralphenazone. |
| Sulpiride | The risk or severity of CNS depression can be increased when Sulpiride is combined with Dichloralphenazone. |
| Alprazolam | The risk or severity of CNS depression can be increased when Alprazolam is combined with Dichloralphenazone. |
| Dexbrompheniramine | The risk or severity of CNS depression can be increased when Dexbrompheniramine is combined with Dichloralphenazone. |